COMMUNIQUÉS West-GlobeNewswire

-
CORRECTION - New Guideline Aims to Transform Obesity Care for Children and Adolescents
14/04/2025 -
European Commission approves Roche’s Columvi as the first bispecific antibody for diffuse large B-cell lymphoma after initial therapy
14/04/2025 -
Press release: CMS Proposes Approval of Additional Payment for Sequana Medical’s alfapump® system in Hospital Inpatient Cases
14/04/2025 -
Sandoz files antitrust litigation against Amgen regarding patient access to etanercept biosimilar in the US
14/04/2025 -
New Guideline Aims to Transform Obesity Care for Children and Adolescents
14/04/2025 -
Turmeric Hack Weight Loss Reviews [Lipozem BHB Complaints & Side Effects Ingredients] Fat Loss Support Supplement
13/04/2025 -
PrimeBiome— How PrimeBiome Gummies Boost Glowing Skin With Bacillus Coagulans & Babchi
12/04/2025 -
Lipozem Reviews (BUYER ALERT!) Is It Legit And Safe To Use? Consumer Report On Reddit Breaks It Down!
12/04/2025 -
Kane Biotech Announces New Agreement with Outside the Box Capital Inc.
12/04/2025 -
TOMI Environmental Solutions, Inc. to Hold Conference Call to Discuss Fourth Quarter 2024 Financial Results on April 14, 2025
12/04/2025 -
Theratechnologies Responds to Future Pak’s Press Release and Announces Exclusive Discussions with Another Potential Acquiror for the Sale of the Company
11/04/2025 -
Theratechnologies réagit à la récente déclaration publique de Future Pak et annonce des discussions exclusives avec un autre acquéreur potentiel pour la vente de la Société
11/04/2025 -
Ontario’s Measles Outbreak Requires Much More Visible & Effective Public Health Response
11/04/2025 -
DBV Technologies announces filing of 2024 Annual Report on Form 10-K and Universal Registration Document
11/04/2025 -
DBV Technologies publie son « Form 10-K » américain et son Document d’Enregistrement Universel 2024
11/04/2025 -
Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
11/04/2025 -
Ocular Therapeutix™ Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
11/04/2025 -
Titan Pharmaceuticals Announces $1 Million Private Placement of Convertible Preferred Stock
11/04/2025 -
Polyrizon Receives Nasdaq Notification Regarding Minimum Bid Requirements
11/04/2025
Pages